<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR88610-0103 </DOCNO><DOCID>fr.6-10-88.f2.A1102</DOCID><TEXT><ITAG tagnum="69"><ITAG tagnum="56">National Institute of Allergy and Infectious Diseases; Open Meetingof Clinical Applications, Prevention and Treatment Subcommittee, Epidemiologyand Technology Transfer Subcommittee of the Acquired Immunodeficiency SyndromeResearch Review Committee </ITAG>Pursuant to Pub. L. 92-463, notice is hereby given of the meeting of theClinical Applications, Prevention and Treatment Subcommittee, and the Epidemiologyand Technology Transfer Subcommittee of the Acquired Immunodeficiency SyndromeResearch Review Committee, National Institute of Allergy and InfectiousDiseases, on June 27-30, 1988, in Conference Room 6, Building 31C, at theNational Institutes of Health, Bethesda, Maryland 20892.The meeting will be open to the public from 8:30 a.m. to 9:10 a.m. on June27 to discuss administrative details relating to committee business andfor program review. Attendance by the public will be limited to space available.In accordance with the provisions set forth in andSection;andSection; 552b(c)(4)and 552b(c)(6), Title 5, U.S.C. and andSection; 10(d) of Pub. L. 92-463,the meeting of the Clinical Applications, Prevention and Treatment Subcommittee,and the Epidemiology and Technology Transfer Subcommittee will be closedto the public for the review, discussion, and evaluation of individualgrant applications and contract proposals from 9:10 a.m. until recess onJune 27, from 8:30 a.m. until recess on June 28, from 8:30 a.m. until recesson June 29, and from 8:30 a.m. until adjournment on June 30. These applications, proposals, and discussions could reveal confidentialtrade secrets or commercial property such as patentable material and personalinformation concerning individuals associated with the applications andproposals, the disclosure of which would constitute a clearly unwarrantedinvasion of personal privacy. Ms. Patricia Randall, Office of Research Reporting and Public Response,National Institute of Allergy and Infectious Diseases, Building 31, Room7A32, National Institutes of Health, Bethesda, Maryland 20892, telephone(301-496-5717), will provide a summary of the meeting and a roster of thecommittee members upon request.Dr. James A. Ferguson, Acting Executive Secretary, Acquired ImmunodeficiencySyndrome Research Review Committee, NIAID, NIH, Westwood Building, Room704, Bethesda, Maryland 20892, telephone (301-496-7630), will provide substantiveprogram information.<ITAG tagnum="20">(Catalog of Federal Domestic Assistance Program Nos. 13.855, PharmacologicalSciences; 13.856, Microbiology and Infectious Diseases Research, NationalInstitutes of Health)</ITAG><ITAG tagnum="21">Dated: June 2, 1988. </ITAG><ITAG tagnum="6">Betty J. Beveridge,</ITAG><ITAG tagnum="4">Committee Management Officer, NIH.</ITAG><ITAG tagnum="40">[FR Doc. 88-13118 Filed 6-9-88; 8:45 am]</ITAG><ITAG tagnum="68">BILLING CODE 4140-01-M</ITAG></ITAG></TEXT></DOC>